The House of Lords Clarifies “Biogen Insufficiency”
DOI:
https://doi.org/10.2966/scrip.060309.718Abstract
The author considers the recent House of Lords’ jurisprudence on “Biogen insufficiency”, arising from its 1997 decision in Biogen Inc v Medeva Plc, which holds that unless claims in the patent specification correspond to the teachings of the patent, the patent will be invalid.Downloads
Download data is not yet available.



